Literature DB >> 20625449

Fuchs' corneal dystrophy.

Allen O Eghrari1, John D Gottsch.   

Abstract

Fuchs' corneal dystrophy (FCD) is a progressive, hereditary disease of the cornea first described a century ago by the Austrian ophthalmologist Ernst Fuchs. Patients often present in the fifth to sixth decade of life with blurry morning vision that increases in duration as the disease progresses. Primarily a condition of the posterior cornea, characteristic features include the formation of focal excrescences of Descemet membrane termed 'guttae', loss of endothelial cell density and end-stage disease manifested by corneal edema and the formation of epithelial bullae. Recent advances in our understanding of the genetic and pathophysiological mechanisms of the disease, as well as the application of new imaging modalities and less invasive surgical procedures, present new opportunities for improved outcomes among patients with FCD.

Entities:  

Year:  2010        PMID: 20625449      PMCID: PMC2897712          DOI: 10.1586/eop.10.8

Source DB:  PubMed          Journal:  Expert Rev Ophthalmol        ISSN: 1746-9899


  139 in total

1.  Posterior lamellar keratoplasty.

Authors:  C W TILLETT
Journal:  Am J Ophthalmol       Date:  1956-03       Impact factor: 5.258

2.  Linkage of late-onset Fuchs corneal dystrophy to a novel locus at 13pTel-13q12.13.

Authors:  Olof H Sundin; Albert S Jun; Karl W Broman; Sammy H Liu; Siobhan E Sheehan; Elizabeth C L Vito; Walter J Stark; John D Gottsch
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-01       Impact factor: 4.799

3.  [Contribution of confocal microscopy and anterior chamber OCT to the study of corneal endothelial pathologies].

Authors:  N Fayol; A Labbé; S Dupont-Monod; B Dupas; C Baudouin
Journal:  J Fr Ophtalmol       Date:  2007-04       Impact factor: 0.818

4.  Changing indications for keratoplasty.

Authors:  R J Morris; A K Bates
Journal:  Eye (Lond)       Date:  1989       Impact factor: 3.775

5.  Central corneal endothelial guttae and age-related macular degeneration: is there an association?

Authors:  G P Rao; S B Kaye; A Agius-Fernandez
Journal:  Indian J Ophthalmol       Date:  1998-09       Impact factor: 1.848

6.  Altered expression of aquaporins in bullous keratopathy and Fuchs' dystrophy corneas.

Authors:  M Cristina Kenney; Shari R Atilano; Nadia Zorapapel; Bret Holguin; Ronald N Gaster; Alexander V Ljubimov
Journal:  J Histochem Cytochem       Date:  2004-10       Impact factor: 2.479

7.  Postnatal development of corneal endothelium.

Authors:  C F Bahn; R M Glassman; D K MacCallum; J H Lillie; R F Meyer; B J Robinson; N M Rich
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-01       Impact factor: 4.799

8.  Histopathological diagnosis of corneal button specimens: an epidemiological study.

Authors:  Katyanne D Godeiro; Anamaria B Coutinho; Patricia R Pereira; Bruno F Fernandes; Amanda Cassie; Miguel N Burnier
Journal:  Ophthalmic Epidemiol       Date:  2007 Mar-Apr       Impact factor: 1.648

9.  Endothelial keratoplasty for Fuchs' dystrophy with cataract: complications and clinical results with the new triple procedure.

Authors:  Mark A Terry; Neda Shamie; Edwin S Chen; Paul M Phillips; Anand K Shah; Karen L Hoar; Daniel J Friend
Journal:  Ophthalmology       Date:  2009-02-08       Impact factor: 12.079

10.  Transplantation of a sheet of human corneal endothelial cell in a rabbit model.

Authors:  Kouichiro Hitani; Seiichi Yokoo; Norihiko Honda; Tomohiko Usui; Satoru Yamagami; Shiro Amano
Journal:  Mol Vis       Date:  2008-01-03       Impact factor: 2.367

View more
  40 in total

Review 1.  Molecular bases of corneal endothelial dystrophies.

Authors:  Thore Schmedt; Mariana Mazzini Silva; Alireza Ziaei; Ula Jurkunas
Journal:  Exp Eye Res       Date:  2011-08-10       Impact factor: 3.467

2.  FUCHS ENDOTHELIAL CORNEAL DYSTROPHY: IS FEMTOSECOND LASER-ASSISTED CATARACT SURGERY THE RIGHT APPROACH?

Authors:  Monica Gavriş; Ioan Horge; Elena Avram; Roxana Belicioiu; Ioana Alexandra Olteanu; Hanga Kedves
Journal:  Rom J Ophthalmol       Date:  2015 Jul-Sep

3.  Co-registered combined OCT and THz imaging to extract depth and refractive index of a tissue-equivalent test object.

Authors:  A J Fitzgerald; X Tie; M J Hackmann; B Cense; A P Gibson; V P Wallace
Journal:  Biomed Opt Express       Date:  2020-02-19       Impact factor: 3.732

4.  Relationship of Fuchs endothelial corneal dystrophy severity to central corneal thickness.

Authors:  Laura J Kopplin; Katie Przepyszny; Brian Schmotzer; Karen Rudo; Denise C Babineau; Sanjay V Patel; David D Verdier; Ula Jurkunas; Sudha K Iyengar; Jonathan H Lass
Journal:  Arch Ophthalmol       Date:  2012-04

5.  Smartphone-based imaging of the corneal endothelium at sub-cellular resolution.

Authors:  Devrim Toslak; Damber Thapa; Muhammet Kazim Erol; Yanjun Chen; Xincheng Yao
Journal:  J Mod Opt       Date:  2016-12-25       Impact factor: 1.464

6.  Qualitative and Quantitative Analysis of the Corneal Endothelium With Smartphone Specular Microscopy.

Authors:  Michael J Fliotsos; Shiva Deljookorani; Daliya Dzhaber; Subhangi Chandan; Mehrnaz Ighani; Allen O Eghrari
Journal:  Cornea       Date:  2020-07       Impact factor: 2.651

7.  The genetics of Fuchs' corneal dystrophy.

Authors:  Benjamin W Iliff; S Amer Riazuddin; John D Gottsch
Journal:  Expert Rev Ophthalmol       Date:  2012-08

8.  Pilot Study of Audiometric Patterns in Fuchs Corneal Dystrophy.

Authors:  Nicholas S Reed; Jennifer A Deal; Matthew G Huddle; Joshua F Betz; Bethany E Bailey; Elyse J McGlumphy; Allen O Eghrari; S Amer Riazuddin; Frank R Lin; John D Gottsch
Journal:  J Speech Lang Hear Res       Date:  2018-10-26       Impact factor: 2.297

Review 9.  Corneal endothelium: developmental strategies for regeneration.

Authors:  J Zavala; G R López Jaime; C A Rodríguez Barrientos; J Valdez-Garcia
Journal:  Eye (Lond)       Date:  2013-03-08       Impact factor: 3.775

Review 10.  Fuchs endothelial cornea dystrophy: a review of the genetics behind disease development.

Authors:  Cecily E Hamill; Thore Schmedt; Ula Jurkunas
Journal:  Semin Ophthalmol       Date:  2013 Sep-Nov       Impact factor: 1.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.